Fortis Healthcare Limited

NSE FORTIS.NS

Fortis Healthcare Limited Price to Sales Ratio (P/S) on February 07, 2025: 6.83

Fortis Healthcare Limited Price to Sales Ratio (P/S) is 6.83 on February 07, 2025, a 27.04% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Fortis Healthcare Limited 52-week high Price to Sales Ratio (P/S) is 8.23 on January 07, 2025, which is 20.50% above the current Price to Sales Ratio (P/S).
Fortis Healthcare Limited 52-week low Price to Sales Ratio (P/S) is 4.53 on March 06, 2024, which is -33.61% below the current Price to Sales Ratio (P/S).
Fortis Healthcare Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 5.96.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: FORTIS.NS

Fortis Healthcare Limited

CEO	Dr. Ashutosh Raghuvanshi
IPO Date	May 9, 2007
Location	India
Headquarters	Tower A
Employees	12,088
Sector	Healthcare
Industries Hospitals & Clinics 3D Printing Biotechnology Dental Care Drugstores & Retail Pharmacies Medical Instruments Pharmaceuticals Telehealth

Description

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.

Key trends

Past 5 years